{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:44:08Z","timestamp":1785861848192,"version":"3.56.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/cad.0b013e328011512d","type":"journal-article","created":{"date-parts":[[2007,1,29]],"date-time":"2007-01-29T04:00:58Z","timestamp":1170043258000},"page":"301-310","source":"Crossref","is-referenced-by-count":4,"title":["Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study"],"prefix":"10.1097","volume":"18","author":[{"given":"Tomasz","family":"Kryczka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zygmunt","family":"Kazimierczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Koz\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw J.","family":"Chrapusta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Vilpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Vilpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Stachnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Janisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Grieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.V81.3.597.597","article-title":"Relationship of deoxycytidine kinase and cytoplasmic 5\u2032-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine","volume":"81","author":"Kawasaki","year":"1993","journal-title":"Blood"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1999.tb01114.x","article-title":"2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland","volume":"62","author":"Robak","year":"1999","journal-title":"Eur J Haematol"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10428199709109163","article-title":"Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma","volume":"26","author":"Robak","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11864-006-0013-x","article-title":"New agents in chronic lymphocytic leukemia","volume":"7","author":"Robak","year":"2006","journal-title":"Curr Treat Options Oncol"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2141.2005.05948.x","article-title":"Guidelines on the management of Waldenstrom macroglobulinaemia","volume":"132","author":"Johnson","year":"2006","journal-title":"Br J Haematol"},{"key":"R8-10-20210203","first-page":"1959","article-title":"In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia","volume":"10","author":"Begleiter","year":"1996","journal-title":"Leukemia"},{"key":"R9-10-20210203","first-page":"756","article-title":"Chlorambucil synergizes with purine analogs in inducing in vitro cytotoxicity in B-cell chronic lymphocytic leukemia","volume":"83","author":"Callea","year":"1998","journal-title":"Haematologica"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10428199909093735","article-title":"Cytotoxicity of 2-chlorodeoxadenosine (cladribine, 2-cdA) in combination with other chemotherapy drugs against two lymphoma cell lines","volume":"33","author":"Hoffman","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bjc.6690195","article-title":"Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies","volume":"79","author":"Laurencet","year":"1999","journal-title":"Br J Cancer"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cncr.11000","article-title":"Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia","volume":"97","author":"Montillo","year":"2003","journal-title":"Cancer"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.leu.2402216","article-title":"Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia","volume":"15","author":"Robak","year":"2001","journal-title":"Leukemia"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.thj.6200191","article-title":"Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia","volume":"3","author":"Robak","year":"2002","journal-title":"Hematol J"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1994.12.3.569","article-title":"Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma","volume":"12","author":"Tefferi","year":"1994","journal-title":"J Clin Oncol"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000421-199910000-00018","article-title":"Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia","volume":"22","author":"Tefferi","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/sonc.2003.50070","article-title":"2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia","volume":"30","author":"Weber","year":"2003","journal-title":"Semin Oncol"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.leu.2402172","article-title":"A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia","volume":"15","author":"Tefferi","year":"2001","journal-title":"Leukemia"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2005-12-4828","article-title":"Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)","volume":"108","author":"Robak","year":"2006","journal-title":"Blood"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/dmd.30.5.488","article-title":"Current progress on esterases: from molecular structure to function","volume":"30","author":"Satoh","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"R21-10-20210203","first-page":"2605","article-title":"Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan","volume":"8","author":"Xu","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00299875","article-title":"Studies on the mechanism of gastrointestinal absorption of melphalan and chlorambucil","volume":"17","author":"Adair","year":"1986","journal-title":"Cancer Chemother Pharmacol"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(86)90183-3","article-title":"An improved colorimetric assay for interleukin 2","volume":"93","author":"Tada","year":"1986","journal-title":"J Immunol Methods"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-1981-29317","article-title":"The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products","author":"Mitsunobu","year":"1981","journal-title":"Synthesis"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0223-5234(01)01229-6","article-title":"Esters of chlorambucil with 2-substituted 1,4-dihydroxy-9,10-anthraquinones as multifunctional anticancer agents","volume":"36","author":"Jin","year":"2001","journal-title":"Eur J Med Chem"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0960-894X(01)00067-1","article-title":"Synthesis and antitumor activity of novel paclitaxel\u2013chlorambucil hybrids","volume":"11","author":"Wittman","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0223-5234(01)01232-6","article-title":"Synthesis, molecular modelling, and antiproliferative and cytotoxic effects of carbocyclic derivatives of distamycin with chlorambucil moiety","volume":"36","author":"Bartulewicz","year":"2001","journal-title":"Eur J Med Chem"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2004.04.001","article-title":"Amidine analogue of chlorambucil is a stronger inhibitor of protein and DNA synthesis in breast cancer MCF-7 cells than is the parent drug","volume":"492","author":"Sienkiewicz","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.bmcl.2005.05.052","article-title":"Synthesis and biological activity of mustard derivatives of combretastatins","volume":"15","author":"Coggiola","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00001813-200606000-00004","article-title":"Structure\u2013anti-leukemic activity relationship study of B- and D-ring modified and non-modified steroidal esters of chlorambucil","volume":"17","author":"Fousteris","year":"2006","journal-title":"Anticancer Drugs"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00001813-200511000-00006","article-title":"Structure\u2013anti-leukemic activity relationship study of B- and D-ring modified and non-modified steroidal esters of chlorambucil's active metabolite","volume":"16","author":"Papageorgiou","year":"2005","journal-title":"Anticancer Drugs"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00001813-200411000-00008","article-title":"The allylic 7-ketone at the steroidal skeleton is crucial for the antileukemic potency of chlorambucil's active metabolite steroidal esters","volume":"15","author":"Arsenou","year":"2004","journal-title":"Anticancer Drugs"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00001813-200207000-00011","article-title":"7-Keto hybrid steroidal esters of nitrogen mustard: cytogenetic and antineoplastic effects","volume":"13","author":"Karayianni","year":"2002","journal-title":"Anticancer Drugs"},{"key":"R34-10-20210203","first-page":"115","article-title":"Prednimustine","volume":"50","year":"1990","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"R35-10-20210203","first-page":"485","article-title":"Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase","volume":"34","author":"Parker","year":"1988","journal-title":"Mol Pharmacol"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0301-472X(03)00083-3","article-title":"PARP-1, a determinant of cell survival in response to DNA damage","volume":"31","author":"Bouchard","year":"2003","journal-title":"Exp Hematol"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/tx0256735","article-title":"Reactions of N,N-bis(2-chloroethyl)-p-aminophenylbutyric acid (chlorambucil) with 2\u2032-deoxyadenosine","volume":"16","author":"Florea-Wang","year":"2003","journal-title":"Chem Res Toxicol"},{"key":"R38-10-20210203","doi-asserted-by":"crossref","first-page":"129","DOI":"10.18388\/abp.2002_3829","article-title":"5\u2032-Esters of 2\u2032-deoxyadenosine and 2-chloro-2\u2032-deoxyadenosine with cell differentiation-provoking agents","volume":"49","author":"Grieb","year":"2002","journal-title":"Acta Biochim Pol"},{"key":"R39-10-20210203","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1124\/jpet.103.056499","article-title":"Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration","volume":"307","author":"Imai","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R40-10-20210203","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00204-001-0318-2","article-title":"Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin","volume":"76","author":"Noort","year":"2002","journal-title":"Arch Toxicol"},{"key":"R41-10-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0009-2797(97)03758-7","article-title":"Kinetics of chlorambucil in vitro: effects of fluid matrix, human gastric juice, plasma proteins and red cells","volume":"103","author":"Lof","year":"1997","journal-title":"Chem Biol Interact"},{"key":"R42-10-20210203","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0959-8049(02)00813-4","article-title":"Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver","volume":"39","author":"van der Wilt","year":"2003","journal-title":"Eur J Cancer"},{"key":"R43-10-20210203","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.bi.57.070188.002025","article-title":"Interactions between deoxyribonucleotide and DNA synthesis","volume":"57","author":"Reichard","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"R44-10-20210203","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0006-2952(90)90383-V","article-title":"Cytotoxicity of chlorambucil and chlorambucil\u2013fatty acid conjugates against human lymphomas and normal human peripheral blood lymphocytes","volume":"40","author":"Anel","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"R45-10-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0008-6215(99)00030-0","article-title":"Alkylating agents from sugars. Alkyl hexopyranoside derivatives as carrier systems for chlorambucil","volume":"316","author":"Iglesias-Guerra","year":"1999","journal-title":"Carbohydr Res"},{"key":"R46-10-20210203","first-page":"290","article-title":"Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase","volume":"56","author":"Bielawska","year":"2001","journal-title":"Pharmazie"},{"key":"R47-10-20210203","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0014-827X(00)00095-1","article-title":"Prolidase-activated prodrug for cancer chemotherapy cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells","volume":"55","author":"Bielawska","year":"2000","journal-title":"Farmaco"},{"key":"R48-10-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3835(94)90278-X","article-title":"The comparative toxicity of chlorambucil and chlorambucil\u2013spermidine conjugate to BALB\/c mice","volume":"85","author":"Verschoyle","year":"1994","journal-title":"Cancer Lett"},{"key":"R49-10-20210203","first-page":"373","article-title":"Synthesis, DNA binding, and sequence specificity of DNA alkylation by some novel cyclic peptide-chlorambucil conjugates","volume":"10","author":"Sheh","year":"1995","journal-title":"Anticancer Drug Des"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004691-200606000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:44:03Z","timestamp":1785858243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200703000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328011512d","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}